Journal Information

Statistics

Follow this link to access the full text of the article

Correspondence
No evidence for cardiotoxicity of miltefosine
Thomas P.C. Dorloa,b,
Corresponding author
thomasdorlo@gmail.com

Corresponding author.
a Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Amsterdam, The Netherlands
b Department of Pharmacy, Uppsala University, Uppsala, Sweden
Read
5283
Times
was read the article
2015
Total PDF
3268
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 20 11 31
2025 5 133 56 189
2025 4 149 33 182
2025 3 139 55 194
2025 2 129 80 209
2025 1 123 50 173
2024 12 96 47 143
2024 11 122 48 170
2024 10 125 69 194
2024 9 155 79 234
2024 8 173 106 279
2024 7 168 103 271
2024 6 118 66 184
2024 5 114 56 170
2024 4 97 78 175
2024 3 90 55 145
2024 2 111 75 186
2024 1 107 39 146
2023 12 58 47 105
2023 11 69 102 171
2023 10 59 65 124
2023 9 68 72 140
2023 8 49 28 77
2023 7 44 21 65
2023 6 39 33 72
2023 5 37 18 55
2023 4 37 18 55
2023 3 43 41 84
2023 2 33 32 65
2023 1 41 34 75
2022 12 37 28 65
2022 11 70 48 118
2022 10 133 55 188
2022 9 57 73 130
2022 8 65 59 124
2022 7 114 74 188
2022 6 46 61 107
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.